Jiangbo Pharmaceuticals Announces Receipt of NASDAQ Delisting Notice
LAIYANG, China, Aug. 2, 2011 /PRNewswire-Asia-FirstCall/ -- Jiangbo Pharmaceuticals, Inc. (Nasdaq: JGBO) ("Jiangbo" or the "Company"), a pharmaceutical company with its principal operations in the People's Republic of China ("China"), today announced that it has received a letter dated July 26, 2011...
Jiangbo Pharmaceuticals Announces Third Quarter Fiscal Year 2011 Results
-- Conference call scheduled at 8:30 a.m. Eastern Time on Wednesday, May 25, 2011 -- LAIYANG, China, May 25, 2011 /PRNewswire-Asia/ -- Jiangbo Pharmaceuticals, Inc. (Nasdaq: JGBO) ("Jiangbo" or the "Company"), a pharmaceutical company with its principal operations in the People's Republic of Chin...
Jiangbo Pharmaceuticals Appoints Interim CFO
LAIYANG, China, May 16, 2011 /PRNewswire-Asia-FirstCall/ -- Jiangbo Pharmaceuticals, Inc. (Nasdaq: JGBO) ("Jiangbo" or the "Company"), a pharmaceutical company with its principal operations in the People's Republic of China ("China"), today announced the appointment of Ms. Ziling Sun as the Company'...
Jiangbo Pharmaceuticals Signs Letter of Intent to Acquire Regional Wholesale Drug Distributor in Shandong Province
LAIYANG, China, April 18, 2011 /PRNewswire-Asia/ -- Jiangbo Pharmaceuticals, Inc. (Nasdaq: JGBO) ("Jiangbo" or the "Company"), a pharmaceutical company with its principal operations in the People's Republic of China ("China"), today announced that Laiyang Jiangbo Pharmaceutical Co., Ltd., a limited ...
Jiangbo Pharmaceuticals Engages New Independent Auditor
LAIYANG, China, April 4, 2011 /PRNewswire-Asia-FirstCall/ -- Jiangbo Pharmaceuticals, Inc. (Nasdaq: JGBO) ("Jiangbo" or the "Company"), a pharmaceutical company with its principal operations in the People's Republic of China ("China"), today announced that the Company has appointed Bernstein & Pinch...
Jiangbo Pharmaceuticals Announces Resignation of its Chief Financial Officer
LAIYANG, China, March 20, 2011 /PRNewswire-Asia-FirstCall/ -- Jiangbo Pharmaceuticals, Inc. (Nasdaq: JGBO) ("Jiangbo" or the "Company"), a pharmaceutical company with its principal operations in the People's Republic of China, today announced that Elsa Sung, the Company's Chief Financial Officer, wi...
Jiangbo Pharmaceuticals Announces Second Quarter Fiscal Year 2011 Results
LAIYANG, China, Feb. 23, 2011 /PRNewswire-Asia-FirstCall/ -- Jiangbo Pharmaceuticals, Inc. (Nasdaq: JGBO) ("Jiangbo" or the "Company"), a pharmaceutical company with its principal operations in the People's Republic of China, today announced its second quarter fiscal year 2011 financial results f...
Jiangbo Pharmaceuticals Announces Conference Call to Discuss Results for Second Quarter Fiscal 2011
LAIYANG, China, Feb. 22, 2011 /PRNewswire-Asia/ -- Jiangbo Pharmaceuticals, Inc. (Nasdaq: JGBO) (the "Company" or "Jiangbo"), a pharmaceutical company with its principal operations in China, today announced that the Company will host a conference call at 9:00 a.m. Eastern Standard Time on Wednesday,...
Jiangbo Pharmaceuticals Reaches Settlement Agreement with the Holder of its November 2007 Debenture and the Holders of its May 2008 Notes
LAIYANG, China, Jan. 21, 2011 /PRNewswire-Asia-FirstCall/ -- Jiangbo Pharmaceuticals, Inc. (Nasdaq: JGBO) ("Jiangbo Pharmaceuticals" or the "Company"), a pharmaceutical company with its principal operations in the People's Republic of China, today announced that it has reached a settlement with the ...
Jiangbo Pharmaceuticals' Hongrui Factory Receives GMP Certificate
LAIYANG, China, Jan. 4, 2011 /PRNewswire-Asia-FirstCall/ -- Jiangbo Pharmaceuticals, Inc. (Nasdaq: JGBO) ("Jiangbo" or the "Company"), a pharmaceutical company with its principal operations in the People's Republic of China, today announced that its Hongrui factory has been awarded with the Good Man...
Jiangbo Pharmaceuticals Announces Progress in Negotiations with Holders of its November 2007 Debenture and May 2008 Notes
LAIYANG, China, Dec. 3, 2010 /PRNewswire-Asia-FirstCall/ -- Jiangbo Pharmaceuticals, Inc. (Nasdaq: JGBO) ("Jiangbo" or the "Company"), a pharmaceutical company with its principal operations in the People's Republic of China, today announced that negotiations with the holder of its November 2007 Debe...
Jiangbo Pharmaceuticals Announces First Quarter Fiscal Year 2011 Results
LAIYANG, China, Nov. 16, 2010 /PRNewswire-Asia-FirstCall/ -- Jiangbo Pharmaceuticals, Inc. (Nasdaq: JGBO) ("Jiangbo" or the "Company"), a pharmaceutical company with its principal operations in the People's Republic of China, today announced financial results for its first quarter ended September 30...
Jiangbo Pharmaceuticals Announces Conference Call to Discuss Results for First Quarter Fiscal 2011
LAIYANG, China, Nov. 11, 2010 /PRNewswire-Asia-FirstCall/ -- Jiangbo Pharmaceuticals, Inc. (Nasdaq: JGBO( http://studio-5.financialcontent.com/prnews?Page=Quote&Ticker=JGBO )) (the "Company" or "Jiangbo"), a pharmaceutical company with its principal operations in China, today announced that the Comp...
Jiangbo Pharmaceuticals Announces Fourth Quarter and Fiscal Year 2010 Results
LAIYANG, China, Sept. 30 /PRNewswire-Asia-FirstCall/ -- Jiangbo Pharmaceuticals, Inc. (Nasdaq: JGBO) ("Jiangbo" or the "Company"), a pharmaceutical company with its principal operations in the People's Republic of China, today announced financial results for its fourth quarter and fiscal year en...
Jiangbo Pharmaceuticals Announces Conference Call to Discuss Results for Fourth Quarter Fiscal 2010
LAIYANG, China, Sept. 27 /PRNewswire-Asia-FirstCall/ -- Jiangbo Pharmaceuticals, Inc. (Nasdaq: JGBO) (the "Company" or "Jiangbo"), a pharmaceutical company with its principal operations in China, today announced that the Company will host a conference call at 9:00 a.m. Eastern Time on Thursday, ...
Jiangbo Pharmaceuticals Chairman to Ring NASDAQ Opening Bell on August 27, 2010
LAIYANG, China, Aug. 25 /PRNewswire-Asia/ -- Jiangbo Pharmaceuticals, Inc. (Nasdaq: JGBO) (the "Company" or "Jiangbo"), today announced that Mr. Wubo Cao, the Company's Chairman, will ring the Opening Bell at the NASDAQ MarketSite in New York City on Friday, August 27, 2010 at 9:30 a.m. ET to ce...
Jiangbo Pharmaceuticals Announces the Commercial Launch of Felodipine Sustained Release Tablets
LAIYANG, China, Aug. 16 /PRNewswire-Asia-FirstCall/ -- Jiangbo Pharmaceuticals, Inc. (Nasdaq: JGBO) (the "Company" or "Jiangbo"), today announced that the Company received approval from the Shandong Food and Drug Administration ("Shandong FDA") to start the sales of Felodipine sustained release ("SR...
Jiangbo Pharmaceuticals to Attend Global Hunter Securities China Conference
LAIYANG, China, July 9 /PRNewswire-Asia/ -- Jiangbo Pharmaceuticals, Inc. (Nasdaq: JGBO) (the "Company" or "Jiangbo"), today announced that its management will present at the Global Hunter Securities China Investment Conference, which takes place July 11-13, 2010 at the St. Regis Hotel in San Fr...
Jiangbo Pharmaceuticals Announces the Appointment of New Chief Executive Officer
LAIYANG, China, July 1 /PRNewswire-Asia/ -- Jiangbo Pharmaceuticals, Inc. (Nasdaq: JGBO) (the "Company" or "Jiangbo"), today announced the appointment of Mr. Linxian Jin, a pharmaceutical industry veteran in China, as the Company's Chief Executive Officer (CEO) effective July 1, 2010. As part of...
